Metabolic Disorders
GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Metabolic Disorders market. Reports cover market growth forecasts, trends and research, and more.
Browse our full list of Metabolic Disorders market reports here.
- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
- The Price Conversion is only for the Indicative purpose.
- USD — US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
-
Product Insights
Diabetic Neuropathy Global Clinical Trials Review, H2, 2017 Diabetic Neuropathy Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetic Neuropathy Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Neuropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Neuropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Peripheral Neuropathy Global Clinical Trials Review, H2, 2017 Diabetic Peripheral Neuropathy Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetic Peripheral Neuropathy Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Peripheral Neuropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Peripheral Neuropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Diabetic Retinopathy Global Clinical Trials Review, H2, 2017 Diabetic Retinopathy Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Retinopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Retinopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diffuse Diabetic Macular Edema Global Clinical Trials Review, H2, 2017 Diffuse Diabetic Macular Edema Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diffuse Diabetic Macular Edema Global Clinical Trials Review, H2, 2017" provides an overview of Diffuse Diabetic Macular Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Diffuse Diabetic Macular Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H2, 2017 Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H2, 2017" provides an overview of Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Dysbetalipoproteinemia (Type III Hyperlipoproteinemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Dyslipidemia Global Clinical Trials Review, H2, 2017 Dyslipidemia Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Dyslipidemia Global Clinical Trials Review, H2, 2017" provides an overview of Dyslipidemia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyslipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026 EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026
$3,995 | July 2017 Type 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body’s inability to make use of available insulin along with relative insulin deficiency. T2D constitutes approximately 90–95% of all diabetes cases around the world, while type 1 diabetes and gestational diabetes make up the remaining 5–10% of cases. Lifestyle factors such as obesity, physical inactivity, and dietary habits are modifiable risk factors, and can...
-
Product Insights
Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H2, 2017 Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H2, 2017
$2,500 | August 2017 GlobalData's clinical trial report, “Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H2, 2017" provides an overview of Familial Chylomicronemia (Type I Hyperlipoproteinemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Familial Chylomicronemia (Type I Hyperlipoproteinemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017 Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017
$2,500 | August 2017 GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017" provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Gestational Diabetes Global Clinical Trials Review, H2, 2017 Gestational Diabetes Global Clinical Trials Review, H2, 2017
$2,500 | August 2017 GlobalData's clinical trial report, “Gestational Diabetes Global Clinical Trials Review, H2, 2017" provides an overview of Gestational Diabetes clinical trials scenario. This report provides top line data relating to the clinical trials on Gestational Diabetes. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.